LitAlert ~~ GeneLit.com

    • Germline mutations in Chinese ovarian cancer with or without breast cancer.
    • Kwong A, Ho CYS, Shin VY, Au CH, Luk WP, Fung LH, Chan TL, Chan KKL, Ngan HYS, Ma ESK.
    • Mol Genet Genomic Med. 2022 May 24:e1940. doi: 10.1002/mgg3.1940. Epub ahead of print.

    • Talazoparib in BRCA-mutated advanced breast cancer: is earlier better?
    • Boulos M, Moujaes E, Nsouli G, Tfayli A, Kourie HR.
    • Pharmacogenomics. 2022 May 24. doi: 10.2217/pgs-2022-0011. Epub ahead of print.
    • Review

    • Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer.
    • Van Baelen K, Geukens T, Maetens M, Tjan-Heijnen V, Lord CJ, Linn S, Bidard FC, Richard F, Yang WW, Steele RE, Pettitt SJ, Van Ongeval C, De Schepper M, Isnaldi E, Nevelsteen I, Smeets A, Punie K, Voorwerk L, Wildiers H, Floris G, Vincent-Salomon A, Derksen PWB, Neven P, Senkus E, Sawyer E, Kok M, Desmedt C.
    • Ann Oncol. 2022 May 20:S0923-7534(22)01167-X. doi: 10.1016/j.annonc.2022.05.006. Epub ahead of print.
    • Review